Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Antimicrobial Susceptibility Testing Market Be Worth By 2029?
The market size for antimicrobial susceptibility testing has witnessed significant expansion in the previous years. It is projected to escalate from $4.36 billion in 2024 to $4.65 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. Factors like increased healthcare spending, a growing elderly populace, heightened awareness and education, regulatory assistance, and economic progression have contributed to the growth in the historical period.
The market size of antimicrobial susceptibility testing is anticipated to significantly expand in the coming years, projecting to reach $5.76 billion by 2029 with a compound annual growth rate (CAGR) of 5.5%. This growth during the forecast period is driven by the escalating instances of drug-resistant infections, improvements in healthcare infrastructure, focused efforts on drug discovery, and an increase in disposable income. Key trends expected during this period include enhancements in automation and robotics, the application of artificial intelligence and machine learning, multiplexing, integration of telemedicine, and swift AST techniques.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4026&type=smp
What Market Forces Are Contributing To The Growth Of The Antimicrobial Susceptibility Testing Market?
The increase in global infectious diseases has a direct impact on the expansion of the antimicrobial susceptibility testing market. Bacteria, viruses, fungi, and parasites are the primary organisms causing these diseases, and examples of these conditions include bacterial pneumonia, tuberculosis, smallpox, AIDS, and others. The Centers for Disease Control and Prevention, a US national public health institute, noted in March 2024 that there were 9,573 cases of TB in 2023 among individuals whose origin of birth was identified. Out of these, 7,259 (76%) occurred among individuals born outside the U.S., reflecting an 18% rise in comparison to the 6,177 such cases reported in 2022. Hence, the escalating prevalence of infectious diseases propels the growth of the antimicrobial susceptibility testing market.
Which Segments Define The Structure Of The Antimicrobial Susceptibility Testing Market?
The antimicrobial susceptibility testingmarket covered in this report is segmented –
1) By Type: Antibacterial Testing; Antifungal Testing; Antiparasitic Testing; Other Types
2) By Products: Manual Antimicrobial Susceptibility Testing Products; Automated Laboratory Instruments; Consumables
3) By Application: Diagnostics; Drug Discovery and Development; Epidemiology; Other Applications
4) By End User: Hospitals And Diagnostic Centers; Pharmaceutical And Biotechnology Companies; Research And Academic Institutes; Clinical Research Organizations (CROs)
Subsegments:
1) By Antibacterial Testing: Disk Diffusion Method; Broth Dilution Method; E-Test Method; Automated Systems
2) By Antifungal Testing: Broth Dilution Method; Agar Disk Diffusion Method; E-Test Method; Colorimetric Methods
3) By Antiparasitic Testing: In vitro Susceptibility Testing; Microscopic Examination; Molecular Methods
4) By Other Types: Mycobacterial Susceptibility Testing; Biofilm Susceptibility Testing; Combination Antimicrobial Testing
What Strategic Shifts And Innovations Are Influencing The Antimicrobial Susceptibility Testing Market?
The burgeoning utilization of swift antimicrobial susceptibility testing to circumvent antibiotic misuse and deliver effective care is surfacing as a dominant trend in the antimicrobial susceptibility testing market. Numerous strategies exist for conducting antimicrobial susceptibility examinations within minutes or a couple of hours. FISH (Fluorescence in situ hybridization) is predominantly employed in rapid antimicrobial susceptibility analysis. The PNA-FISH method utilises peptide nucleic acid probes that facilitate swift and specific binding. This procedure is implemented in QuickFish technology (OpGen) to execute microbial identification by targeting 16s RNA. As an example, the antimicrobial susceptibility testing system designed by Genefluidics Inc gauges bacterial growth by enumerating 16s rRNA molecules through the usage of an electrochemical biosensor.
Which Firms Are Making The Biggest Impact In The Antimicrobial Susceptibility Testing Market?
Major companies operating in the antimicrobial susceptibility testing market include BioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Hi-Media Laboratories, Creative Diagnostics, Merck KGaA, Roche Diagnostics Limited, Alifax Holding S.p.A., Synbiosis Ltd., Zhuhai DL Biotech Co. Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., Condalab, QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Micromax Technologies, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S, VWR International LLC, ZeptoMetrix Corporation
Access The Complete Report Here:
Which Region Is Forecasted To Lead The Antimicrobial Susceptibility Testing Market In The Coming Years?
North America was the largest region in the antimicrobial susceptibility testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=4026&type=smp
Browse Through More Reports Similar to the Global Antimicrobial Susceptibility Testing Market 2025, By The Business Research Company
Healthcare Analytical Testing Services Global Market Report 2025
Automotive Testing Inspection And Certification Global Market Report 2025
Cold Plasma Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model